XML 55 R34.htm IDEA: XBRL DOCUMENT v3.6.0.2
NET LOSS PER SHARE (Tables)
9 Months Ended 12 Months Ended
Sep. 30, 2016
Dec. 31, 2015
Schedule of anti-dilutive

Dilutive shares which could exist pursuant to the exercise of outstanding stock instruments and which were not included in the calculation because their affect would have been anti-dilutive are as follows:

 

    Nine
Months Ended
September 30,
2016
(Shares)
    Nine
Months Ended
September 30,
2015
(Shares)
 
             
Restricted stock awards – unvested     -       1,160,000  
Shares of common stock     6,219,200       6,219,200  
      6,219,200       7,379,200  
 
QPAGOS Corporation - Parent Company [Member]    
Schedule of anti-dilutive  

Dilutive shares which could exist pursuant to the exercise of outstanding stock instruments and which were not included in the calculation because their affect would have been anti-dilutive are as follows:

 

    Year ended
December 31, 2015
(Shares)
    Year ended
December 31, 2014
(Shares)
 
             
Restricted stock awards – unvested     4,320,000       4,320,000  
Warrants to purchase shares of common stock     6,219,200       -  
      10,539,200       4,320,000